Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Rida

2-amino-5-phosphonovalerate has been researched along with Rida in 1 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Research Excerpts

ExcerptRelevanceReference
"By contrast, cells from scrapie-infected mice fired calcium spikes repetitively and the long, slow AHP, which in control cells inhibited repetitive firing, was absent."1.30Alterations in potassium currents may trigger neurodegeneration in murine scrapie. ( Fraser, JR; Jeffrey, M; Johnston, AR; MacLeod, N, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johnston, AR1
Fraser, JR1
Jeffrey, M1
MacLeod, N1

Other Studies

1 other study available for 2-amino-5-phosphonovalerate and Rida

ArticleYear
Alterations in potassium currents may trigger neurodegeneration in murine scrapie.
    Experimental neurology, 1998, Volume: 151, Issue:2

    Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Animals; Calcium; Electrophysiology; Excitatory Amin

1998